USANA Health Sciences, Inc.
USNA
$19.41
-$0.50-2.51%
NYSE
| 04/04/2026 | 01/03/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 10.62% | 5.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.62% | 5.86% | |||
| Cost of Revenue | 20.30% | 1.21% | |||
| Gross Profit | 7.91% | 7.24% | |||
| SG&A Expenses | 10.88% | -2.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.11% | -1.65% | |||
| Operating Income | -19.57% | 1,309.23% | |||
| Income Before Tax | 270.24% | 132.83% | |||
| Income Tax Expenses | 47.37% | -31.74% | |||
| Earnings from Continuing Operations | 536.30% | 76.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 408.89% | -228.57% | |||
| Net Income | 523.38% | 72.78% | |||
| EBIT | -19.57% | 1,309.23% | |||
| EBITDA | -14.18% | 182.29% | |||
| EPS Basic | 521.13% | 72.79% | |||
| Normalized Basic EPS | -6.05% | 758.35% | |||
| EPS Diluted | 521.13% | 73.06% | |||
| Normalized Diluted EPS | -6.12% | 758.35% | |||
| Average Basic Shares Outstanding | 0.52% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.60% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||